Atlas Trials

Allogeneic hMSC Injection in Patients With Hypoplastic Left Heart Syndrome

Clinical trial NCT02398604 · TERMINATED

Trial details

NCT number
NCT02398604
Sponsor
Longeveron Inc.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Hypoplastic Left Heart Syndrome
Start date
2015-04-01
Primary completion
2019-03-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.